Concepedia

Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: Results of a randomized, double-blind, placebo-controlled trial*

Jean‐Louis Vincent, Herbert Spapen, Jacques Créteur, Michaël Piagnerelli, Ives Hubloue, Marc Diltoer, Alain Roman, E Stevens, Els Vercammen, Jessica S. Beaver

Critical Care Medicine · 2006 · 39 citations · 16 references

DOI

Abstract

Epoetin alfa, once weekly, augmented the erythropoietic response in critically ill patients as indicated by the increased erythropoietin levels and larger AUC(RETI)0-Tlast in treated patients.

References

16

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units

Jean‐Louis Vincent, Arnaldo de Mendonça, F. Cantraine et al. · Critical Care Medicine · 1998 · 3.4K citations

Anemia and Blood Transfusion in Critically Ill Patients

Jean‐Louis Vincent · JAMA · 2002 · 1.8K citations

The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*

Howard L. Corwin, Andrew Gettinger, Ronald G. Pearl et al. · Critical Care Medicine · 2004 · 1.3K citations

Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Timothy J. Littlewood, Emilio Bajetta, J.W.R. Nortier et al. · Journal of Clinical Oncology · 2001 · 976 citations

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

George D. Demetri, Mark G. Kris, James L. Wade et al. · Journal of Clinical Oncology · 1998 · 756 citations